Saturday, 11 April 2026

CWH C1382624

 A

Neonatal enteroviral syndrome refers to severe systemic infection in newborns caused by non-polio enteroviruses (commonly Coxsackievirus B and Echovirus). It typically presents in the first 1–2 weeks of life and can mimic overwhelming sepsis.


Why neonates get severe disease

  • Perinatal transmission (maternal infection around delivery)

  • Immature immune response

  • High viral load → multiorgan involvement


Classic “neonatal enteroviral sepsis syndrome”

Think sepsis + myocarditis + hepatitis:

Common features

  • Fever or temperature instability

  • Lethargy, poor feeding

  • Apnoea

  • Rash (maculopapular / petechial)

  • Irritability

Severe manifestations

  • Myocarditis → tachycardia, shock, arrhythmias

  • Hepatitis → markedly ↑ AST/ALT, coagulopathy, thrombocytopenia

  • Meningitis / encephalitis

  • DIC-like picture

  • Pulmonary haemorrhage (rare but classic exam point)


Red flags suggesting enterovirus (vs bacterial sepsis)

  • Very high transaminases early

  • Low platelets + coagulopathy

  • Myocarditis in first week

  • Maternal “flu-like” illness near delivery

  • Negative bacterial cultures but baby worsening


Investigations (UK practice)

Send PCR for enterovirus:

  • Blood

  • CSF (if stable)

  • Throat swab

  • Stool

Also:

  • LFTs (often very high)

  • Coagulation profile (PT prolonged)

  • Troponin / BNP if myocarditis suspected

  • Echo (for ventricular dysfunction)


Management (NHS approach)

Supportive + treat like sepsis until proven otherwise

  • Broad-spectrum IV antibiotics initially

  • PICU support if shock

  • Inotropes for myocarditis

  • Correct coagulopathy (FFP, cryo)

  • Ventilatory support if needed

Specific therapy

  • IVIG sometimes used (evidence mixed but common in severe disease)

  • No routinely recommended antiviral (pleconaril not standard UK use)


Prognosis

  • Mild meningitis → usually good outcome

  • Fulminant hepatitis/myocarditis → high mortality (up to 30–50%)

  • Survivors usually recover cardiac function


Exam / viva one-liner

Neonatal enteroviral syndrome = early neonatal sepsis with myocarditis, hepatitis, coagulopathy, and negative cultures — confirm with enterovirus PCR.


If you want, I can also give:

  • quick differential vs HSV neonatal sepsis

  • management algorithm

  • when to give IVIG


A

Medical Summary – 11-Day-Old Neonate

Reason for Readmission (Day 5)

  • Excessive weight loss (22.5%)

  • Lethargy, poor feeding, apnoeic episodes

  • Bleeding tendency

  • No vitamin K at birth

Key Problems During Admission

  • Late-onset sepsis with DIC

  • Severe thrombocytopenia (platelets as low as 7 ×10⁹/L)

  • Lethargy and poor feeding

  • Peripheral hypoperfusion (right hand; arterial line related)

  • Difficult IV access

  • Feed intolerance

  • Deranged liver function tests

  • Generalised puffiness/oedema

  • Enterovirus positive (nasopharyngeal aspirate)

  • Elevated BNP and troponin (concern for myocardial involvement)

Initial Management

  • 10 ml/kg 0.9% saline bolus then IV maintenance (subsequently stopped)

  • Two doses vitamin K given

  • Platelet transfusion

  • Long line inserted

  • Broad sepsis workup and monitoring

Investigations

  • CRP 10

  • Hb 185 g/L

  • WBC 28 → 24 ×10⁹/L (neutrophils 18 → 14)

  • Platelets 30 → 10 ×10⁹/L (nadir 7)

  • Sodium 140 → 144 mmol/L

  • Phosphate 1.5 → 1.3 mmol/L

  • INR 8.9 → 1.2 after treatment

  • Blood cultures negative at 36 hrs

  • Ammonia 43

  • CXR: no acute disease

  • Cranial USS ×2: normal

  • MRI head: normal

  • TORCH: negative

  • Abdominal USS: gallbladder wall thickening

  • BNP markedly elevated (22992)

  • Troponin elevated (5452)

Clinical Course

  • Platelets improved to 51 ×10⁹/L post-transfusion

  • Coagulopathy corrected

  • Vitamin K deficiency resolved

  • Ongoing monitoring for myocardial involvement and liver dysfunction

Ongoing / Planned

  • Repeat FBC and coagulation

  • Monitor urine output and blood pressure

  • Daily weights and head circumference

  • Monitor perfusion (consider topical vasodilator if required)

  • HSV PCR (skin and serum)

  • Viral PCRs including adenovirus, CMV, enterovirus

  • Lumbar puncture when platelets >100 ×10⁹/L

  • Continue cefotaxime (minimum 10 days)

  • Continue aciclovir pending HSV results

No comments:

Post a Comment